(Q51577003)

7 April 2018

title

Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients. (English)

1 reference

7 April 2018

0 references

1 reference

1 reference

Féry F

1

1 reference

7 April 2018

Plat L

series ordinal

2

1 reference

7 April 2018

Balasse EO

series ordinal

3

1 reference

7 April 2018

publication date

1 February 1997

1 reference

7 April 2018

published in

Metabolism

1 reference

7 April 2018

volume

46

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

227-233

1 reference

7 April 2018

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

1 reference

Epidemiology of adverse drug reactions to phenformin and metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Role of metformin in treatment of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Effect of metformin on glucose metabolism in the splanchnic bed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Metformin increases insulin sensitivity and basal glucose clearance in Type 2 (non-insulin dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Influences of glucose loading and of injected insulin on hepatic glucose output

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Initial splanchnic extraction of ingested glucose in normal man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

The theoretical bases of indirect calorimetry: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Effect of buformin on splanchnic carbohydrate and substrate metabolism in healthy man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Skeletal muscle is a major site of lactate uptake and release during hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990307-3

10.1016/S0026-0495(97)90307-3

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9030834

1 reference

7 April 2018